Nephrocare Health Services, known for its brand NephroPlus, has filed draft papers with capital markets regulator Securities and Exchange Board of India (SEBI) seeking its clearance to mobilise funds through an initial public offering (IPO). The company's proposed IPO involves a fresh issue of equity shares valued Rs 353.4 crore and an offer for sale (OFS) of 1.27 crore shares by promoters and existing shareholders.
The company proposes to utilize proceeds of the fresh issue to the tune of Rs 129.1 crore for opening new dialysis clinics in India; Rs 136 crore for payment of debt and rest on general corporate purposes. ICICI Securities, Ambit, IIFL Capital Services and Nomura Financial Advisory and Securities (India) have been appointed by the company to manage its maiden public issue.
NephroPlus, incorporated in 2009, provides dialysis services in the country, having 447 clinics across 269 cities in 21 states and 4 Union Territories, and serving more than 33,000 patients globally on an annual basis. It has also expanded its international footprint to include the Philippines (34 clinics), Uzbekistan (4 clinics), Nepal (5 clinics) and has entered the Middle East market through Saudi Arabia recently.
